3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
7
Triple Negative Breast Neoplasms
5
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Head and Neck Neoplasms
1
GastroEsophageal Cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
CLDN18.2 Positive
1
Anal Cancer Metastatic
1
Adenocarcinoma
1
Interventions
Oxaliplatin
8
Fluorouracil
8
Nivolumab
7
Leucovorin
7
Paclitaxel
6
Capecitabine
5
Taxes
4
Specimen Handling
4
pembrolizumab
3
Trastuzumab
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Cisplatin
3
zimberelimab
2
zanidatamab
2
Radiotherapy
2
Folfox protocol
2
Carboplatin
2
zolbetuximab
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tislelizumab
1
quemliclustat
1
obeticholic acid
1
futibatinib
1
dehydroftorafur
1
cixutumumab
1
balstilimab
1
Saline Solution
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Albumin-Bound Paclitaxel
×
30 days
×
Clear all
No trials found.